Proc Natl Acad Sci USA 1985
Studies comparing these analogs have provided insights into how pharmacokinetic properties influence natural effects
Previous clinical studies using L-Carnitine supplementation have noted improvements in some cardiovascular risk factors (such as LDL, total cholesterol, and blood pressure).[3,4,5,8] Supplementation with L-Carnitine has also been found to improve feelings of hunger and fatigue induced by fasting in individuals with metabolic syndrome.[6] And, a 2020 systematic review and meta-analysis of 37 randomized controlled clinical trials found that: l-carnitine supplementation provides a modest reducing effect on body weight, BMI and fat mass, especially among adults with overweight/obesity. [7] It should be noted, though, that a previous 2014 meta-analysis found no benefit from L-carnitine supplementation in patients with cardiovascular disease.[14] Carnitine, Heart Disease & TMAO To further muddy the waters, other research notes an association between carnitine intake and increased plasma levels of pro-atherogenic trimethylamine N-oxide (TMAO).[9,10,16] TMAO has been identified as a risk factor for cardiovascular diseases and reported to be elevated in several cardiovascular events as well as type 2 diabetes
Wemuta-C Injection is administered as an injection by a healthcare professional
